Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adamis, Astrazeneca, Bavarian Nordic, Celltrion, Clarity, Daewoong, Daiichi Sankyo, Elpiscience, Innocare, Innovent, Insilico Medicine, Jacobio, Kazia, Lynk, Olipass, Oncocross, Pharmabcine, Polyactiva, Recce, Simcere, Takeda, TFF, Transcenta.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Bionet Asia, Edesa, Enanta, Gracell, JCR, Laurent, Nrx, Pharmajet, Regencell, Resverlogix, Technovalia.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Akston, Antengene, Ascletis, Astellas, Astrazeneca, Biohaven, Chi-Med, Clarity, Eubiologics, Gilead Sciences, Glenmark, IGM, Kintor, Novavax, Opthea, Otsuka, Pardes, Pfizer, Pop, Prota, RDIF, Recce, Revive, Sanotize R&D, Scancell, Shionogi, Sumitovant, Sunovion, Telix, Windtree.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adlai Nortye, Arcturus, Ascletis, Beigene, Biogen, Biontech, Biothera Solutions, Daewoong, Eisai, Eli Lilly, Galecto, Harbour Biomed, Innovent Biologics, Kintor, Moderna, NLC, Obi, Oncolytic, Pfizer, Remegen, SAB, Telix, TFF, Todos Medical, Valneva.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Angel, Anges, Aslan, Calcimedica, Clover, Corvus, Cstone, Eisai, Elpiscience, Eqrx, HDT, Hinova, Hutchmed, I-Mab, Immvira, Keymed, Lynk, Merck, Recce, Resverlogix, Revelation, Revive, Sciwind, Sorrento, Vasomune.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alar, Ascletis, Bharat Biotech International, Cansino, Cara, Hutchmed, I-Mab, Lianbio, Maruishi, Molecular Partners, Novartis, Ocugen, Pharmamar, Quantum Leap Healthcare Collaborative, Redhill, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adlai Nortye, Asieris, Beigene, Belief Biomed, Bionomics, Celltrion, Clover, Connect, First Wave, Gannex, Golden, Gritstone Oncology, Harbour Biomed, Humanigen, Kintor, Recce, Revive.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Antengene, Astrazeneca, Bharat Biotech, Bio-Thera Solutions, Daiichi Sankyo, Dawnrays, Kiniksa, Kintor, Luye, Novavax, Nykode, Ocugen, Pharmabcine, Pluristem, Revive, Ribomic.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akston, Alphamab, Antengene, Henlius, Kissei, Mereo, Novavax, Rigel, Statera, Sumitomo Dainippon, Telix, Urovant.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: 60 Degrees, Acelyrin, Arcturus, Axcella, Capricor, Douglas, Eiger, Eucure, Geovax, Glaxosmithkline, HDT, Jiangsu Hengrui, Inmagene, Merck, Nicox, Novaliq, Nrx, Nykode, Pfizer, Recce, Ridgeback, Sanofi, Valneva.